How many institutions held FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in Q4 2020?

49 institutional investors reported FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share for Q4 2020. Use the holders table for investor-level position and value details.

Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Q: What does CUSIP 34962G109 represent in this 13F holders report?

CUSIP 34962G109 is the security identifier for FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 34962G109

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 20,563,488
Total 13F shares: 8,392,546
Share change: +1,580,559
Total reported value: $305,570,000
Price per share: $36.41
Number of holders: 49
Value change: +$56,276,590
Number of buys: 33
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 34962G109:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ArrowMark Colorado Holdings LLC	13F	Company	14%	2,936,708	$142,460,000	—	30 Sep 2020	13F
FRANKLIN RESOURCES INC	13F	Company	4.7%	968,858	$46,999,000	—	30 Sep 2020	13F
BVF INC/IL	13F	Company	3.8%	777,553	$37,719,000	—	30 Sep 2020	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	2.3%	465,832	$22,598,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.7%	340,622	$16,523,000	—	30 Sep 2020	13F
ORBIMED ADVISORS LLC	13F	Company	1.7%	340,480	$16,517,000	—	30 Sep 2020	13F
CREDIT SUISSE AG/	13F	Company	0.88%	180,594	$8,760,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	0.8%	165,072	$8,008,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	0.51%	105,164	$5,102,000	—	30 Sep 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.39%	79,823	$3,872,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	76,473	$3,709,000	—	30 Sep 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.21%	43,641	$2,117,000	—	30 Sep 2020	13F
MYDA Advisors LLC	13F	Company	0.17%	34,000	$1,649,000	—	30 Sep 2020	13F
Global IMC LLC	13F	Company	0.15%	31,015	$1,505,000	—	30 Sep 2020	13F
DAVENPORT & Co LLC	13F	Company	0.13%	26,800	$1,300,000	—	30 Sep 2020	13F
Informed Momentum Co LLC	13F	Company	0.11%	21,723	$1,054,000	—	30 Sep 2020	13F
Invesco Ltd.	13F	Company	0.1%	20,601	$999,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.09%	19,504	$946,000	—	30 Sep 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	18,400	$893,000	—	30 Sep 2020	13F
Sepio Capital, LP	13F	Company	0.09%	18,400	$893,000	—	30 Sep 2020	13F
CIBC Private Wealth Group LLC	13F	Company	0.09%	17,666	$857,000	—	30 Sep 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	13,169	$639,000	—	30 Sep 2020	13F
Parkman Healthcare Partners LLC	13F	Company	0.06%	12,500	$606,000	—	30 Sep 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.06%	12,497	$606,000	—	30 Sep 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	12,334	$598,000	—	30 Sep 2020	13F
LPL Financial LLC	13F	Company	0.05%	10,396	$504,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.04%	8,177	$397,000	—	30 Sep 2020	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.04%	8,000	$388,000	—	30 Sep 2020	13F
Athanor Capital, LP	13F	Company	0.03%	6,414	$311,000	—	30 Sep 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	6,319	$307,000	—	30 Sep 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	4,900	$237,000	—	30 Sep 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	4,508	$219,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	0.02%	4,139	$201,000	—	30 Sep 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	3,864	$187,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	3,140	$152,000	—	30 Sep 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,997	$97,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	0%	966	$47,000	—	30 Sep 2020	13F
UBS Group AG	13F	Company	0%	682	$34,000	—	30 Sep 2020	13F
TFC Financial Management, Inc.	13F	Company	0%	504	$24,000	—	30 Sep 2020	13F
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA	13F	Company	0%	193	$9,000	—	30 Sep 2020	13F
CITIGROUP INC	13F	Company	0%	123	$6,000	—	30 Sep 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	115	$6,000	—	30 Sep 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	54	$3,000	—	30 Sep 2020	13F
CWM, LLC	13F	Company	0%	66	$2,000	—	30 Sep 2020	13F
Princeton Global Asset Management LLC	13F	Company	0%	33	$2,000	—	30 Sep 2020	13F
FLAGSHIP HARBOR ADVISORS, LLC	13F	Company	0%	33	$1,000	—	30 Sep 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	13	$1,000	—	30 Sep 2020	13F

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q4 2020

As of 31 Dec 2020, Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,392,546 shares. The largest 10 holders included ArrowMark Colorado Holdings LLC, FRANKLIN RESOURCES INC, BVF INC/IL, FRED ALGER MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Invesco Ltd., and Woodline Partners LP. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.